Stopex Junior 15 mg tablets  Bulgarija - bulgarų - Изпълнителна агенция по лекарствата

stopex junior 15 mg tablets 

walmark a.s. - Декстрометорфан - 15 mg tablets 

Stopex Junior 30 mg tablets  Bulgarija - bulgarų - Изпълнителна агенция по лекарствата

stopex junior 30 mg tablets 

walmark a.s. - Декстрометорфан - 30 mg tablets 

Travmagel 5 % gel Bulgarija - bulgarų - Изпълнителна агенция по лекарствата

travmagel 5 % gel

actavis group ptc ehf. - Диклофенак - 5 % gel

Cefixime Abr 100 mg/5 ml powder for oral suspension Bulgarija - bulgarų - Изпълнителна агенция по лекарствата

cefixime abr 100 mg/5 ml powder for oral suspension

Антибиотик - Разград АД - Цефиксим - 100 mg/5 ml powder for oral suspension

Intratect 100 g/l solution for infusion Bulgarija - bulgarų - Изпълнителна агенция по лекарствата

intratect 100 g/l solution for infusion

biotest pharma gmbh - Имуноглобулин нормален човек за вътресъдова адм. - 100 g/l solution for infusion

Otrivin Menthol 0,1% nasal spray, solution Bulgarija - bulgarų - Изпълнителна агенция по лекарствата

otrivin menthol 0,1% nasal spray, solution

novartis consumer health gmbh - Ксилометазолин - 0,1% nasal spray, solution

Zabdeno Europos Sąjunga - bulgarų - EMA (European Medicines Agency)

zabdeno

janssen-cilag international n.v.    - recombinant adenovirus type 26 (ad26) encoding the glycoprotein (gp) of the ebola virus zaire (zebov) mayinga strain - Хеморагична Треска Ебола - Ваксини - active immunization for prevention of disease caused by ebola virus (zaire ebolavirus species) in individuals ≥ 1 year of age.

Mvabea Europos Sąjunga - bulgarų - EMA (European Medicines Agency)

mvabea

janssen-cilag international n.v.    - recombinant modified vaccinia ankara bavarian nordic virus encoding the: ebola virus zaire (zebov) mayinga strain glycoprotein (gp); ebola virus sudan gulu strain gp; ebola virus taï forest strain nucleoprotein and the marburg virus musoke strain gp - Хеморагична Треска Ебола - Ваксини - active immunization for prevention of disease caused by ebola virus (zaire ebolavirus species) in individuals ≥ 1 year of age.

Vaxneuvance Europos Sąjunga - bulgarų - EMA (European Medicines Agency)

vaxneuvance

merck sharp & dohme b.v.  - pneumococcal polysaccharide conjugate vaccine (adsorbed) - Пневмококови инфекции - pneumococcus, purified polysaccharides antigen conjugated - vaxneuvance is indicated for active immunisation for the prevention of invasive disease, pneumonia and acute otitis media caused by streptococcus pneumoniae in infants, children and adolescents from 6 weeks to less than 18 years of age. vaxneuvance is indicated for active immunisation for the prevention of invasive disease and pneumonia caused by streptococcus pneumoniae in individuals 18 years of age and older. Вижте раздели 4. 4 и 5. 1 за информация относно защитата срещу специфични пневмококови серотипове. the use of vaxneuvance should be in accordance with official recommendations.